Dear Colleagues,

Cardiovascular disease including arrhythmias, cardiomyopathy, and heart failure, and cerebrovascular disease such as stroke is the number one reason for the mortality of humans in 21^st century. Essential metabolic disorders such as hypertension, obesity, diabetes mellitus, lipid metabolic disorders and others are the top risk factors for cardiovascular and cerebrovascular diseases and is prevalent worldwide in epidemic proportions. For example, there is striking proportions of hypertensives in any given population who eventually succumb to cardiovascular diseases and stroke. In addition, in recent decades, lots of researches have been reported that obesity and diabetes mellitus were significantly associated with cardiovascular diseases in the general population. Even more, more and more studies reveal that various lipid metabolic disorders and cardiovascular diseases commonly coexist. However, the molecular genetics and causality of metabolic disorders in cardiovascular and cerebrovascular diseases remains not clear known, and understanding of the molecular genetics and genomics of this area is still a major challenge at present. Therefore, this special issue provides us with an opportunity to deeply discuss the molecular genetics and genomics of metabolic disorders in cardiovascular and cerebrovascular diseases. In this special issue, we welcome submissions of Original Research (basic and clinical research), Case Report and Review articles focusing on, but not limited to, the aspect of the molecular genetics and genomics of metabolic disorders in cardiovascular and cerebrovascular diseases.

Dr. Lingfeng Zha

Section Editors